Showing results 6 to 9 of 9
< previous
| Title | Author(s) | Issue Date | |
|---|---|---|---|
Regular virologic surveillance showed very frequent cytomegalovirus reactivation in patients treated with alemtuzumab Journal:American Journal of Hematology | 2007 | ||
| 2008 | |||
Rituximab increases the risk of de novo hepatitis B infection in hepatitis B surface antigen negative patients undergoing cytotoxic chemotherapy Proceeding/Conference:Journal of Gastroenterology and Hepatology | 2006 | ||
| 2004 |